NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/21/2026
Back to search
Official data from USPTO
FLEX PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
07/21/2026
Trademark type
Word
Nice classes
42
Filing date
04/09/2025
Registration date
07/21/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/21/2026
Last transaction
07/21/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/09/2025
First use in commerce
01/14/2026
Drawing code
4
Owner type
16
Owner location
New Brighton, MN, US
Examiner
DIGAN, MATTHEW M
Law office
N60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Flex Pharma, LLC
Representatives
James A Wahl Lathrop GPM LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Pharmaceutical research and development; Pharmaceutical products development; Consulting services in the field of pharmaceutical research and development
Publications
History of USPTO decisions and trademark events.
22 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/21/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/30/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/30/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/30/2026
IUAF
USE AMENDMENT FILED
04/13/2026
EISU
TEAS STATEMENT OF USE RECEIVED
04/13/2026
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/24/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/27/2026
PUBO
PUBLISHED FOR OPPOSITION
01/27/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/21/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/03/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/25/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/25/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/25/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/04/2025
GNRT
NON-FINAL ACTION E-MAILED
09/04/2025
CNRT
NON-FINAL ACTION WRITTEN
09/04/2025
DOCK
ASSIGNED TO EXAMINER
09/04/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/11/2025
MAFR
APPLICATION FILING RECEIPT MAILED
04/09/2025
NWAP
NEW APPLICATION ENTERED
04/09/2025
Continuous trademark protection
Get notified about every new filing that threatens FLEX PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.